Back to Search Start Over

Phase II trial uses combination of antiviral drugs and Remune

Source :
AIDS Weekly. Feb 24, 1997, p9, 2 p.
Publication Year :
1997

Abstract

The Immune Response Corp., Carlsbad, California, announced that it has begun a 32-week Phase II combination drug trial combining Remune with triple antiviral drug therapy consisting of AZT, 3TC, and [...]

Details

ISSN :
10691456
Database :
Gale General OneFile
Journal :
AIDS Weekly
Publication Type :
News
Accession number :
edsgcl.19154995